Publications
CIBMTR Publication List
Since 1972, using CIBMTR data and statistical resources has resulted in more than 1,800 publications.
CIBMTR also makes its publication analysis datasets freely available to the public for secondary analysis while safeguarding participants' privacy and protecting confidential and proprietary data.
Browse Publications
2025 | American Journal of Hematology
Germline pathogenic variants in MUTYH are associated with inferior survival after hematopoietic cell transplantation in patients with hematologic malignancies or disorders.
Authors:
Rafati M, Wang Y, Koppayi AL, Savage SA, Godley LA, Williams KM, Porter C, Jones K, Hicks B, Spellman SR, He M, Atshan R, Iwuagwu C, Bolon YT, Arrieta-Bolaños E, Saultz JN, Benjamin CL, Lee SJ, Saber W, Gadalla SM
2025 | Transplantation and Cellular Therapy
Post-Transplant Cyclophosphamide improves survival in HLA-DPB1 mismatched unrelated donor allogeneic transplantation.
Authors:
McCurdy SR, Solomon SR, Shaffer BC, He M, Bolon YT, Blouin AG, Keyzner A, Socola FA, Ibrahim U, Zou J, Safah H, Saba N, Gadalla S, Perales MA, Paczesny S, Marsh SGE, Petersdorf EW, Wang T, Lee SJ, Fuchs EJ
2025 | Transplantation and Cellular Therapy
Choosing between HLA-mismatched unrelated and haploidentical donors: Donor age considerations.
Authors:
Mehta RS, Schmidt G, Williams K, Patel SA, Schetelig J, Savani B, Askar M, Petersdorf E, Ringden O, Kanakry CG, Kanakry JA, Stefanski H, Arrieta-Bolaños E, Betts B, Benjamin C, Gadalla S, Wang T, Saultz J, Spellman S, Jurdi NE, Bolon YT, Lee SJ
2025 | Frontiers in Immunology
Long donor leukocyte telomeres raise risk of severe COVID-19 in recipients of allogeneic hematopoietic cell transplant.
Authors:
Mendez KJW, Lai TP, Spellman SR, Verhulst S, Anderson J, Saber W, Gadalla SM, Aviv A
2025 | American Journal of Hematology
Donor age matters for haploidentical HCT patients even after adjusting for HLA factors: A machine learning approach.
Authors:
Mehta RS, Sparapani R, Wang T, Spellman SR, Lee SJ, Petersdorf EW
2025 | Blood Advances
Transplant outcomes Using Older Matched Sibling Donors Compared to Young Alternative Donors: A CIBMTR Analysis.
Authors:
Nath K, Zhang MJ, Bye M, Abid MB, Benjamin C, Betts BC, Bhatt NS, Arrieta-Bolaños E, Bolon YT, Gadalla SM, Grunwald MR, Krem MM, Lee SJ, Marsh SGE, Martino R, Mehta PA, Milano F, Prestidge T, Saultz JN, Shaw BE, Spellman SR, Choe HK, Shaffer BC
2025 | Transplantation and Cellular Therapy
The association of HLA-E ligand and NKG2 receptor variation with relapse and mortality after haploidentical related donor transplantation.
Authors:
Petersdorf EW, McKallor C, Malkki M, Hsu K, He M, Spellman SR, Gooley T, Stevenson P
2024 | Clinical Transplantation
Novel scoring system for ranking hematopoietic stem cell transplantation.
Authors:
Baxter-Lowe LA, Wang T, Kuxhausen M, Spellman SR, Maiers M, Lee SJ, Saultz J, Arrieta-Bolaños E, Gadalla SG, Bolon Y, Betts BC
2024 | British Journal of Haematology
Telomere length and clonal chromosomal alterations in peripheral blood of patients with severe aplastic anaemia.
Authors:
Strauss JD, Brown DW, Zhou W, Dagnall C, Yuan J, Im A, Savage SA, Wang Y, Rafati M, Spellman SR, Gadalla SM
2024 | Proceedings of the National Academy of ...
The health risk of social disadvantage is transplantable into a new host.
Authors:
Turcotte LM, Wang T, Beyer KM, Cole SW, Spellman SR, Allbee-Johnson M, Williams E, Zhou Y, Verneris MR, Rizzo JD, Knight JM
2024 | Blood Advances
Interplay between donor age and HLA-DP matching in 10/10 HLA-matched unrelated donor HCT.
Authors:
Mehta RS, Petersdorf EW, Wang T, Spellman SR, Lee SJ
2024 | Transplantation and Cellular Therapy
Hemophagocytic lymphohistiocytosis gene variants in severe aplastic anemia and their impact on hematopoietic cell transplantation outcomes.
Authors:
Rafati M, McReynolds LJ, Wang Y, Hicks B, Jones K, Spellman SR, He M, Bolon YT, Arrieta-Bolaños E, Saultz JN, Lee SJ, Savage SA, Gadalla SM
2024 | Frontiers in Genetics
Donor whole blood DNA methylation is not a strong predictor of acute graft versus host disease in unrelated donor allogeneic haematopoietic cell transplantation.
Authors:
Webster AP, Ecker S, Moghul I, Liu X, Dhami P, Marzi S, Paul DS, Kuxhausen M, Lee SJ, Spellman SR, Wang T, Feber A, Rakyan V, Peggs KS, Beck S
2024 | Frontiers in Immunology
Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: No land in sight.
Authors:
Schetelig J, Baldauf H, Heidenreich F, Hoogenboom JD, Spellman SR, Kulagin A, Schroeder T, Sengeloev H, Dreger P, Forcade E, Vydra J, Wagner-Drouet EM, Choi G, Paneesha S, Miranda NAA, Tanase A, de Wreede LC, Lange V, Schmidt AH, Sauter J, Fein JA, Bolon YT, He M, Marsh SGE, Gadalla SM, Paczesny S, Ruggeri A, Chabannon C, Fleischhauer K
2024 | Blood Advances
Combined effect of unrelated donor age and HLA peptide-binding motif match status on HCT outcomes.
Authors:
Mehta RS, Petersdorf EW, Spellman SR, Lee SJ
2023 | Blood Advances
Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML.
Authors:
Fein JA, Shouval R, Krieger E, Spellman SR, Wang T, Baldauf H, Fleischhauer K, Kröger N, Horowitz M, Maiers M, Miller JS, Mohty M, Nagler A, Weisdorf D, Malmberg KJ, Toor AA, Schetelig J, Romee R, Koreth J
2023 | Journal of Clinical Oncology
HLA haplotypes and relapse after hematopoietic cell transplantation.
Authors:
Petersdorf EW, McKallor C, Malkki M, He M, Spellman SR, Gooley T, Stevenson P
2023 | Blood Advances
JAK2 V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes.
Authors:
Rafati M, Brown DW, Zhou W, Jones K, Luo W, St Martin A, Wang Y, He M, Spellman SR, Wang T, Deeg HJ, Gupta V, Lee SJ, Bolon YT, Chanock SJ, Machiela MJ, Saber W, Gadalla SM
2023 | American Journal of Hematology
Associations of minor histocompatibility antigens with outcomes following allogeneic hematopoietic cell transplantation.
Authors:
Jadi O, Tang H, Olsen K, Vensko S, Zhu Q, Wang Y, Haiman CA, Pooler L, Sheng X, Brock G, Webb A, Pasquini MC, McCarthy PL, Spellman SR, Hahn T, Vincent B, Armistead P, Sucheston-Campbell LE
2023 | Transplantation and Cellular Therapy
HLA class I genotype is associated with relapse risk after allogeneic stem cell transplantation for NPM1-mutated acute myeloid leukemia.
Authors:
Narayan R, Niroula A, Wang T, Kuxhausen M, He M, Meyer E, Chen YB, Bhatt VR, Beitinjaneh A, Nishihori T, Sharma A, Brown VI, Kamoun M, Diaz MA, Abid MB, Askar M, Kanakry CG, Gragert L, Bolon YT, Marsh SGE, Gadalla SM, Paczesny S, Spellman S, Lee SJ